A Multidisciplinary Approach to the Treatment of Prostate Cancer: Providing Therapies that Improve Overall Survival and Quality of Life

1.5 hour activity | ACCME, ACPE, AANP, ANCC

Course Description
Originally a live, CME-certified 90-minute ancillary symposium will be developed for the AUA 2017 meeting titled, A Multidisciplinary Approach to the Treatment of Prostate Cancer: Providing Therapies that Improve Overall Survival and Quality of Life. In order to extend the reach of the live program to include urologists who were not able to attend the AUA meeting or the symposium, a virtual symposium with audio and downloadable slides from the live program will be hosted for a period of one year.

Course opens: 09/18/2017

Course expires: 10/18/2018

Target Audience
This activity is intended for urologists, medical, surgical, and radiation oncologists, and other healthcare professionals involved in treating patients with prostate cancer.

Learning Objectives
Upon completion of the educational activity, participants should be able to:
  • Incorporate validated, evidence-based guidelines on the management of patients with prostate cancer
  • Apply emerging clinical data on the management of patients with advanced, castrate-resistant prostate cancer Integrate available technologies into clinical practice for early detection, disease typing, and disease monitoring
  • Integrate a multidisciplinary team approach with medical, surgical, and radiation oncologists into daily practice in treating patients with prostate cancer.
Faculty
CHAIR
Oliver Dartor, M.D.
C.E. & Bernadine Laborde Professor for Cancer Research
Medical Director, Tulane Cancer Center
Assistant Dean for Oncology
Tulane Medical School
New Orleans, LA
Consultant: AstraZeneca, Bayer, Bellicum, Bristol-Myers Squibb, Celgene, Dendreon, EMD Serono, Johnson & Johnson, Medivation, Oncogenex, Sanofi-Aventis, Tokai
Grant/Research support: Bayer, Endocyte, Innocrin, Johnson & Johnson, Sanofi-Aventis
NRG: Co-chairman of GU Committee

Judd W. Moul, MD, FACS
James H. Semans, MD Professor of Surgery
Director, Duke Prostate Center
Division of Urologic Surgery
Duke University Medical Center
Durham, NC
Speakers Bureau: Bayer Oncology, Dendreon, Ferring, Janssen, Sanofi, Genome Dx, Genomic Health
Consultant: Theralogix LLD, Abbvie
Contracted Research: Astellas, Pfizer

Fred Saad, MD, FRCSC
Professor & Chair of Urology
Director of G-U Oncology
Endowed Chair in Prostate Cancer Research University of Montreal
Montreal, Quebec, Canada
Consultant: Astellas, Janssen, Sanofi, Bayer, Amgen, Roche
Contracted Research: Astellas, Janssen, Sanofi, Bayer, Amgen, AstraZeneca, Merck

AKH planners and reviewers have no relevant financial relationships to disclose.

Criteria for Success
In order to receive credit, participants should watch the entire video. Once you have watched the video, you will continue to the online quiz and evaluation. A passing score of 70% on the quiz is required to receive credit. A certificate will be available in your transcripts upon successful completion of the quiz and evaluation. If you have questions about this CME/CE activity, please contact AKH Inc. at kwolynski@akhcme.com.
There is no fee for this activity

CME/CE Credit provided by AKH Inc., Advancing Knowledge in Healthcare
Physicians
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Center of Excellence Media, LLC – An affiliate of The Lynx Group. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME.

Pharmacy
custom image
AKH Inc., Advancing Knowledge in Healthcare is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. AKH Inc., Advancing Knowledge in Healthcare approves this knowledge-based activity for 1.5 contact hour(s) (0.15 CEUs). 0077-9999-17-038-H04-P. Initial Release Date: 9/18/2017

Nursing
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is awarded 1.5 Contact Hours.

Nurse Practitioners
custom image
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Center of Excellence Media, LLC – An affiliate of The Lynx Group. AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803
This activity is accredited for 1.5 contact hour(s) which includes 0 hour(s) of pharmacology. Activity ID # 21812

Commercial Support
This activity is supported by an educational grant from Sanofi Genzyme.


Disclosures 
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.  

Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. 

Disclaimer
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant's misunderstanding of the content.

Required hardware/software:
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.